Profil
David Peritt worked as Director-Biosimilars Biology at Pfizer Inc. from 2015 to 2016 and as Chief Technology Officer at Sigilon Therapeutics, Inc. from 2017 to 2021.
He holds a doctorate degree from the University of Pennsylvania.
Anciens postes connus de David Peritt
| Sociétés | Poste | Fin |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/04/2021 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2016 |
Formation de David Peritt
| University of Pennsylvania | Doctorate Degree |
Expériences
Fonctions occupées
Relations
59
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |